sales@reportocean.com (Bussiness Sales)
+18882123539 (Us - Toll Free)
+919997112116 (Rest Of World)
Blood Market by Product [Whole Blood Collection (System and Reagents), Source Plasma Collections (System and Reagents) Blood Therapeutics (IVIG, Albumin, Hyperimmune, Factor VIII, Factor IX, and Others), Blood Typing Products (System and Reagents), Blood Screening (Systems and Reagents), Blood Processing Equipment & Associated Products (System and Reagents)] and End User (Blood & Blood Component Bank, Diagnostic Laboratories, Ambulatory Surgical Centers, Hospitals, and Others): Global Opportunity Analysis and Industry Forecast, 2017-2023

Blood Market by Product [Whole Blood Collection (System and Reagents),...

Home / Categories / Healthcare
Blood Market by Product [Whole Blood Collection (System and Reagents), Source Plasma Collections (System and Reagents) Blood Therapeutics (IVIG, Albumin, Hyperimmune, Factor VIII, Factor IX, and Others), Blood Typing Products (System and Reagents), Blood Screening (Systems and Reagents), Blood Processing Equipment & Associated Products (System and Reagents)] and End User (Blood & Blood Component Bank, Diagnostic Laboratories, Ambulatory Surgical Centers, Hospitals, and Others): Global Opportunity Analysis and Industry Forecast, 2017-2023
Blood Market by Product [Whole...
Report Code
RO1/113/1191

Publish Date
01/May/2017

Pages
63
PRICE
$ 1800/-
This is a single user license, allowing one specific user access to the product. The product is a PDF.
$ 2350/-
This is a 1-5 user license, allowing up to five users have access to the product. The product is a PDF.
$ 2850/-
This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF..
CHAPTER 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top winning strategies
3.2.2. Top investment pockets

3.3. MARKET SHARE ANALYSIS,2016
3.4. PORTERS FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS

3.5.1. Drivers

3.5.1.1. Increase in geriatric population
3.5.1.2. Technological advancement in medical technology for donor screening
3.5.1.3. Advancement in blood transfusion instruments

3.5.2. Restraints

3.5.2.1. Advancement in minimal invasive technology

3.5.3. Opportunities

3.5.3.1. Improvement in the healthcare facilities in Asia-Pacific

CHAPTER 4 BLOOD MARKET, BY PRODUCT

4.1. OVERVIEW
4.2. WHOLE BLOOD COLLECTION

4.2.1. Key market trends
4.2.2. Key growth factors and opportunities
4.2.3. Market size and forecast
4.2.4. Market by whole blood collection type

4.2.4.1. Whole Blood Collection Systems

4.2.4.1.1. Market size and forecast

4.2.4.2. Whole Blood Collection Reagents

4.2.4.2.1. Market size and forecast

4.3. SOURCE PLASMA COLLECTION

4.3.1. Key market trends
4.3.2. Key growth factors and opportunities
4.3.3. Market size and forecast
4.3.4. Source Plasma Collection Systems

4.3.4.1. Market size and forecast

4.3.5. Source Plasma Collection Reagents

4.3.5.1. Market size and forecast

4.4. BLOOD THERAPEUTICS

4.4.1. Key market trends
4.4.2. Key growth factors and opportunities
4.4.3. Market size and forecast
4.4.4. IVIG (Intravenous Immunoglobulin)

4.4.4.1. Market size and forecast

4.4.5. Factor IX

4.4.5.1. Market size and forecast

4.4.6. Factor VIII

4.4.6.1. Market size and forecast

4.4.7. Factor IX

4.4.7.1. Market size and forecast

4.4.8. Hyperimmune

4.4.8.1. Market size and forecast

4.4.9. Albumins

4.4.9.1. Market size and forecast

4.4.10. Others

4.4.10.1. Market size and forecast

4.5. BLOOD TYPING PRODUCTS

4.5.1. Key market trends
4.5.2. Key growth factors and opportunities
4.5.3. Market size and forecast
4.5.4. Blood Typing Systems

4.5.4.1. Market size and forecast

4.5.5. Blood Typing Reagents

4.5.5.1. Market size and forecast

4.6. BLOOD SCREENING

4.6.1. Key market trends
4.6.2. Key growth factors and opportunities
4.6.3. Market size and forecast
4.6.4. Blood Screening Systems

4.6.4.1. Market size and forecast

4.6.5. Blood Screening Reagents

4.6.5.1. Market size and forecast

4.7. BLOOD PROCESSING EQUIPMENT AND ASSOCIATED PRODUCTS

4.7.1. Key market trends
4.7.2. Key growth factors and opportunities
4.7.3. Market size and forecast
4.7.4. Blood Processing Equipment Systems

4.7.4.1. Market size and forecast

4.7.5. Blood Processing Equipment Reagents

4.7.5.1. Market size and forecast

CHAPTER 5 BLOOD MARKET, BY END USER

5.1. OVERVIEW
5.2. BLOOD & BLOOD COMPONENT BANK

5.2.1. Market size and forecast

5.3. DIAGNOSTIC LABORATORIES

5.3.1. Market size and forecast

5.4. AMBULATORY SURGICAL CENTERS

5.4.1. Market size and forecast

5.5. HOSPITALS

5.5.1. Market size and forecast

CHAPTER 6 BLOOD MARKET, BY GEOGRAPHY

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. NORTH AMERICA

6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. Market size and forecast
6.2.4. U.S.: market size and forecast
6.2.5. Canada: market size and forecast
6.2.6. Mexico: market size and forecast

6.3. EUROPE

6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Market size and forecast
6.3.4. Germany: market size and forecast
6.3.5. France market size and forecast
6.3.6. UK: market size and forecast
6.3.7. Italy: market size and forecast
6.3.8. Spain: market size and forecast
6.3.9. Rest of Europe: market size and forecast

6.4. ASIA-PACIFIC

6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Market size and forecast
6.4.4. Japan: market size and forecast
6.4.5. China market size and forecast
6.4.6. India: market size and forecast
6.4.7. Rest of Asia-Pacific market size and forecast

6.5. LAMEA

6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. Market size and forecast
6.5.4. Latin America: market size and forecast
6.5.5. Middle East market size and forecast
6.5.6. Africa: market size and forecast

CHAPTER 7 COMPANY PROFILES

7.1. ABBOTT LABORATORIES

7.1.1. Overview
7.1.1. Operating business segments
7.1.1. Business performance
7.1.2. Key strategic moves & developments

7.2. BAXTER INTERNATIONAL INC.

7.2.1. Overview
7.2.2. Operating business segments
7.2.3. Business performance
7.2.4. Key strategic moves & developments

7.3. BECTON, DICKINSON & CO.

7.3.1. Overview
7.3.2. Operating business segments
7.3.3. Business performance
7.3.4. Key strategic moves & developments

7.4. CSL BEHRING

7.4.1. Overview
7.4.2. Operating business segments
7.4.3. Business performance
7.4.4. Key strategic moves & developments

7.5. IMMUCOR

7.5.1. Overview
7.5.2. Operating business segments
7.5.3. Business performance
7.5.4. Key strategic moves & developments

7.6. NOVARTIS

7.6.1. Overview
7.6.2. Operating business segments
7.6.3. Business performance
7.6.4. Key strategic moves & developments

7.7. NOVO NORDISK

7.7.1. Overview
7.7.2. Operating business segments
7.7.3. Business performance
7.7.4. Key strategic moves & developments

7.8. ORTHO CLINICAL DIAGNOSTICS

7.8.1. Overview
7.8.2. Operating business segments
7.8.3. Business performance
7.8.4. Key strategic moves & developments

7.9. ROCHE DIAGNOSTICS

7.9.1. Overview
7.9.2. Operating business segments
7.9.3. Business performance
7.9.4. Key strategic moves & developments

7.10. GRIFOLS INTERNATIONAL SA

7.10.1. Overview
7.10.2. Operating business segments
7.10.3. Business performance
7.10.4. Key strategic moves & developments

OUR CLIENTS

500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
+18882123539
sales@reportocean.com